Cold Sore Treatment Market, By Product Type (Topical Treatments, Oral Treatments, Light-Based Treatments), By Cold Sore Type (Primary Outbreaks and Recurrent Outbreaks), By Age Group (Children and Adolescents and Adults), By Distribution Channel (Hospital

Cold Sore Treatment Market, By Product Type (Topical Treatments, Oral Treatments, Light-Based Treatments), By Cold Sore Type (Primary Outbreaks and Recurrent Outbreaks), By Age Group (Children and Adolescents and Adults), By Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Online Pharmacy), By Geography (North America, Latin America, Europe, Asia Pacific, Middle East & Africa)

Cold sores, also known as fever blisters or oral herpes, are small, fluid-filled blisters that form around or inside the mouth. These are most commonly caused by the Herpes simplex virus type 1 (HSV-1). Global cold sore treatment market growth is driven by rising prevalence of HSV-1 infections worldwide. Advancements in treatment drugs and drugs in the pipeline promises high treatment effectiveness with reduced side effects.

Market Dynamics:

Global cold sore treatment market growth is driven by growing prevalence of HSV-1 infections globally. According to the WHO, around 3.7 billion people under the age of 50 years are infected with HSV-1 worldwide. Developing easier, safer and more effective treatment options can offer market growth opportunities. However, lack of permanent cure and high recurrence rate of cold sores can hamper the market growth. Innovation in drugs development to provide a potential cure and prevent cold sore recurrence can offer opportunities for market players during the forecast period.

Key features of the study:

• This report provides in-depth analysis of the global cold sore treatment market, and provides market size (USD Billion) and compound annual growth rate (CAGR%) for the forecast period (2024–2031), considering 2023 as the base year
• It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
• This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
• It profiles key players in the global cold sore treatment market based on the following parameters – company highlights, products portfolio, key highlights, financial performance, and strategies
• Key companies covered as a part of this study include Ablynx NV, Teva Pharmaceutical Industries Ltd., Merix Pharmaceutical Corp., Medivir AB, and AiCuris Anti-infective Cures GmbH
• Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
• Global cold sore treatment market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
• Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global cold sore treatment market

Detailed Segmentation-

• By Product Type Insights (Revenue, USD Bn, 2019 - 2031)
• Topical Treatments
• Creams and Ointments
• Acyclovir
• Penciclovir
• Docosanol
• Other Topical Treatments
• Medicated Lip Balms and Patches
• Oral Treatments
• Antiviral Medications
• Valacyclovir
• Famciclovir
• Acyclovir
• Over-the-Counter Medications
• Light-Based Treatments
• Laser Therapy
• Photodynamic Therapy
• By Cold Sore Type Insights (Revenue, USD Bn, 2019 - 2031)
• Primary Outbreaks
• Recurrent Outbreaks
• By Age Group Insights (Revenue, USD Bn, 2019 - 2031)
• Children and Adolescents
• Adults
• By Distribution Channel Insights (Revenue, USD Bn, 2019 - 2031)
• Hospital Pharmacy
• Retail Pharmacy
• Online Pharmacy
• Regional Insights (Revenue, USD Bn, 2019 - 2031)
• North America
• U.S.
• Canada
• Latin America
• Brazil
• Argentina
• Mexico
• Rest of Latin America
• Europe
• Germany
• U.K.
• Spain
• France
• Italy
• Russia
• Rest of Europe
• Asia Pacific
• China
• India
• Japan
• Australia
• South Korea
• ASEAN
• Rest of Asia Pacific
• Middle East
• GCC Countries
• Israel
• Rest of Middle East
• Africa
• South Africa
• North Africa
• Central Africa
• Key Players Insights
• GSK plc
• Novartis AG
• Teva Pharmaceuticals USA, Inc.
• AbbVie Inc.
• Merck & Co., Inc.
• Pfizer Inc.
• Sanofi
• Mylan N.V.
• Aurobindo Pharma
• Reddy's Laboratories
• Amgen Inc.
• GlaxoSmithKline
• Ferring Pharmaceuticals
• HRA Pharma
• Quantum Health
• Church & Dwight Co., Inc.
• Perrigo Company plc
• Biofrontera AG
• Bausch Health Companies Inc.
• Meda Pharmaceuticals